Delivery Order SPE2DB22D2206-SPE2DB24FEB68
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,426.82, is for the delivery of Remicade 100 mg vials, a specialty medication. The contract has an ultimate completion date of November 13, 2024 and is structured as a Firm Fixed Price Delivery Order. This contract award is part of a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Remicade 100 mg vials. The contract, valued at $14,718, is a delivery order with a firm fixed price and an ultimate completion date of August 8, 2023. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,064.64 firm-fixed-price delivery order is for 100 mg vials of the medication Remicade. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical division. The IDC, which runs through November 2026, enables the efficient procurement of a comprehensive...
- This federal contract award, valued at $12,745.09, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is for the delivery of Remicade 100 mg vials, a pharmaceutical product, with a completion date of April 18, 2024. This is a delivery order contract with a firm fixed price pricing type. The award is not associated with any set-aside...
- This federal contract award, valued at $17,086.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Remicade 100 mg vials, a specialty medication used in the treatment of various medical conditions. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Remicade 100 mg vials. The award, valued at $36,787.74, is a firm-fixed-price delivery order that will be completed by November 2, 2023. The contract is not designated as a set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999,...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for 4,561,093,813 units of Remicade 100 mg vials. The contract has a ceiling value of $14,384.65 and a completion date of June 1, 2023. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,326.75 firm fixed-price delivery order contract is for the supply of Remicade 100 mg vials, a specialty medication. The contract has an ultimate completion date of March 27, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award to AmerisourceBergen Drug Corp is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract award, valued at $78,531.28, is for the supply of REMICADE 100MG 20ML 1S, which are pharmaceutical products used in medical treatment. The contract does not have a set-aside designation, indicating open competition. As a major...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $41,679.13, is for the delivery of Remicade 100 mg vials to support federal healthcare programs. The contract is a Firm Fixed Price Delivery Order, with a completion date of January 3, 2024. It is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FEB68Delivery Order
This federal contract award, valued at $24,148.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is a delivery order (Contract #SPE2DB22D2206) under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 and running through November 2026. The contract is for the delivery of Remicade 100 mg vials, a specialty pharmaceutical product. This award does not have a set-aside designation, indicating open competition. As a major pharmaceutical distributor, AmerisourceBergen has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company's extensive supply chain and distribution capabilities enable it to efficiently fulfill government contracts for a wide range of essential medical commodities, supporting the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.1k | 11/8/23 |